The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition

被引:0
作者
Michio Yoshimura
Chikako Yamauchi
Naoko Sanuki
Yasushi Hamamoto
Kimiko Hirata
Jiro Kawamori
Mariko Kawamura
Mami Ogita
Yutaka Yamamoto
Hiroji Iwata
Shigehira Saji
机构
[1] Kyoto University Graduate School of Medicine,Department of Radiation Oncology and Image
[2] Shiga General Hospital,Applied Therapy
[3] Yokkaichi Municipal Hospital,Department of Radiation Oncology
[4] National Hospital Organization Shikoku Cancer Center,Department of Radiology
[5] Kyoto City Hospital,Department of Radiation Oncology
[6] St. Luke’s International Hospital,Department of Radiation Oncology
[7] Nagoya University Graduate School of Medicine,Department of Radiation Oncology
[8] The University of Tokyo Hospital,Department of Radiology
[9] Kumamoto University Graduate School of Medical Science,Department of Radiology
[10] Aichi Cancer Center Hospital,Department of Breast and Endocrine Surgery
[11] Fukushima Medical University,Department of Breast Oncology
来源
Breast Cancer | 2024年 / 31卷
关键词
Clinical practice guideline; Clinical question; Radiation therapy; Radiotherapy; Breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
The Breast Cancer Clinical Practice Guidelines, organized by the Japanese Breast Cancer Society (JBCS), were published in 2022. We present the English version of the Radiation Therapy (RT) section of the guidelines. The JBCS formed a task force to update the 2018 version of the JBCS Clinical Practice Guidelines. The Background Questions (BQs) contain the standard treatments for breast cancer in clinical practice, whereas the Clinical Questions (CQs) address daily clinical questions that remain controversial. Future Research Questions (FRQs) explore the subjects that are considered important issues, despite there being insufficient data for inclusion as CQs. The task force selected the 12 BQs, 8 CQs, and 6 FRQs for the RT section. For each CQ, systematic literature reviews and meta-analyses were conducted according to the Minds Manual for Guideline Development 2020, version 3.0. The recommendations, strength of recommendation, and strength of evidence for each CQ were determined based on systematic reviews and meta-analyses, and finalized by voting at the recommendation decision meeting.
引用
收藏
页码:347 / 357
页数:10
相关论文
共 247 条
[1]  
Whelan TJ(2010)Long-term results of hypofractionated radiation therapy for breast cancer N Engl J Med 362 513-520
[2]  
Pignol JP(2013)The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials Lancet Oncol 14 1086-1094
[3]  
Levine MN(2011)Fractionation for whole breast irradiation: an American society for radiation oncology (ASTRO) evidence-based guideline Int J Radiat Oncol Biol Phys 81 59-68
[4]  
Julian JA(2018)Radiation therapy for the whole breast: executive summary of an American society for radiation oncology (ASTRO) evidence-based guideline Pract Radiat Oncol 8 145-152
[5]  
MacKenzie R(2021)Final analysis of a multicenter single-arm confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906 Jpn J Clin Oncol 51 865-872
[6]  
Parpia S(2014)Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast Int J Radiat Oncol Biol Phys 90 1017-1024
[7]  
Haviland JS(2020)Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial J Clin Oncol 38 3615-3625
[8]  
Owen JR(2015)Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial Lancet Oncol 16 47-56
[9]  
Dewar JA(2019)The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation Radiat Oncol 14 121-497
[10]  
Agrawal RK(2013)Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis Int J Radiat Oncol Biol Phys 86 491-1068